Table of Contents Table of Contents
Previous Page  714 / 1631 Next Page
Information
Show Menu
Previous Page 714 / 1631 Next Page
Page Background

Response Rates and Progression-free Survival with

Obinutuzumab–Chlorambucil versus Rituximab–Chlorambucil.